Clinical Trials on Major Depression Mild

Total 11723 results

Vanderbilt University
National Institute of Mental Health (NIMH)

Completed

Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression

Major Depressive Disorder

United States
Massachusetts General Hospital
Bristol-Myers Squibb

Completed

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy

Major Depressive Disorder

United States
Icahn School of Medicine at Mount Sinai

Terminated

Cysteamine Therapy for Major Depressive Disorder

Major Depressive Disorder

United States
Pfizer

Completed

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Major Depressive Disorder

United States, Mexico
BlackThorn Therapeutics, Inc.

Completed

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR)

Completed

Mental Health Telemetry for Self-Management in Major Depression (MHTV)

Major Depressive Disorder

Canada
Hoffmann-La Roche

Completed

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Major Depressive Disorder

United States, Germany, Austria, Russian Federation, Ukraine, Canada, Slovakia, South Africa
Perry Renshaw

Completed

Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder

Major Depressive Disorder

United States
Sanofi

Completed

An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder

Major Depressive Disorder

United States, France, Sweden, Mexico, Argentina, Finland
Massachusetts General Hospital
American Foundation for Suicide Prevention

Completed

Trial of a Positive Psychology Intervention in Major Depressive Disorder (HOPE)

Major Depressive Disorder

United States
Brown University
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression

Major Depressive Disorder

United States
Central Arkansas Veterans Healthcare System
National Center for PTSD

Withdrawn

Mobile Apps for the Treatment of Depression

Major Depressive Disorder

United States
Euthymics BioScience, Inc.

Completed

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Major Depressive Disorder

United States
MindApps

Withdrawn

Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder

Major Depressive Disorder

United States
Ministry of Health & Welfare, Korea

Terminated

Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients

Major Depressive Disorder

Korea, Republic of
Universitaire Ziekenhuizen KU Leuven
Medtronic

Terminated

Deep Brain Stimulation in Treatment Refractory Depression (DBSTRD)

Major Depressive Disorder

Belgium
Janssen Research & Development, LLC

Completed

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Major Depressive Disorder

Ukraine, Bulgaria, Romania, Russian Federation, Hungary, Moldova, Republic of
University of Calgary
University of Alberta

Unknown

Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis

Major Depressive Disorder

Canada
University of California, San Francisco
National Center for Complementary and Integrative Health (NCCIH)

Completed

Practicing Alternative Techniques to Heal From Depression: The PATH-D Study (PATH-D)

Major Depressive Disorder

United States
Takeda

Completed

Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder

Major Depressive Disorder

Japan
H. Lundbeck A/S

Completed

Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries

Major Depressive Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression

Major Depressive Disorder

United States
Capital Medical University

Completed

The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial

Major Depressive Disorder

China
University of California, Los Angeles

Completed

Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)

Major Depressive Disorder

United States
Ewha Womans University
GlaxoSmithKline

Completed

Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Somerset Pharmaceuticals

Completed

Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression

Major Depressive Disorder

United States
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Completed

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder

Major Depressive Disorder

China
Neuronetics

Completed

Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States
Icahn School of Medicine at Mount Sinai

Completed

Cognitive Training for Depression

Major Depressive Disorder

United States
Targacept Inc.

Completed

TC-5214 as add-on the Treatment of Major Depressive Disorder

Depression | Major Depressive Disorder

United States, India
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Biomarkers for Outcomes In Late-life Depression (BOLD) (BOLD)

Major Depressive Disorder

United States
Sanofi

Completed

An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients (FIDELIO)

Major Depressive Disorder

Romania, Russian Federation, Ukraine, Mexico, Slovakia, Chile, South Africa
Samsung Medical Center

Completed

Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder (CAMPION)

Major Depressive Disorder

Korea, Republic of
Sunovion

Withdrawn

Major Depressive Disorder With Mixed Features (RESOLVE2)

Major Depressive Disorder

United States
AstraZeneca

Terminated

6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Major Depressive Disorder (MDD)

Depression

Spain
University of Arizona
Eli Lilly and Company

Completed

Duloxetine for Perimenopausal Depression

Major Depressive Disorder

United States
Pharmacology Research Institute

Unknown

Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Shi Jinyun

Unknown

Study of Ketamine as an Antidepressant in Major Depressive Disorder

Major Depressive Disorder

China
Labopharm Inc.

Completed

A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.

Major Depressive Disorder

United States, Canada
Centre for Addiction and Mental Health

Completed

Transcranial Direct Current Stimulation (tDCS) in the Treatment of Major Depressive Disorder (MDD)

Major Depressive Disorder

Canada
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy

Major Depressive Disorder

United States
Sheba Medical Center

Withdrawn

Hormonal Levels in Men With Major Depressive Disorder

Depression
Charite University, Berlin, Germany
H. Lundbeck A/S

Completed

Investigation of a Combination Treatment of Escitalopram and rTMS

Major Depressive Disorder

Germany
Solvay Pharmaceuticals

Completed

Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents

Major Depressive Disorder

Japan
Community Pharmacology Services Ltd

Completed

Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD

Major Depressive Disorder

United Kingdom
Eli Lilly and Company

Completed

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Major Depressive Disorder

United States, Puerto Rico
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder

Major Depressive Disorder

Clinical Trials on Major Depression Mild

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations